Approvals, trial readouts, recall alerts and market moves — verified trade news for hospital, clinic and global procurement teams.
A new bimekizumab PsA trial readout from BE BOLD shows dual IL-17A/IL-17F inhibition (bimekizumab, Bimzelx) beats IL-23 …
Thomas Müller
A new CGM type 2 diabetes readout from the CONNECT trial shows continuous glucose monitoring cuts A1c more than standard…
Read more
A new proton therapy prostate readout from the large COMPPARE study suggests the two modern radiotherapy options produce…
Read more
A new fenebrutinib MS trial may be the first win for BTK inhibitors (BTKis) in multiple sclerosis (MS). The oral drug be…
Read more
A new low-calorie diet AF trial in JAMA shows older patients with persistent atrial fibrillation can drop real weight an…
Read more
A new Nature Medicine study shows antibiotics gut microbiome effects can last up to 8 years. The strongest signals come …
Read more
Datopotamab deruxtecan has a second US breast cancer green light now. The FDA cleared the Daiichi Sankyo and AstraZeneca…
Read more
Pulse Biosciences shared one-year clinical results for its nanosecond PFA system that could reshape the atrial fibrillat…
Read more
A new WHO Europe AI health report shows artificial intelligence is now woven into clinical workflows across the European…
Read more
A new EphA2 minibody PET imaging method from the University of Missouri lights up cancer tumors during a PET scan. The w…
Read more
AI-powered AF detection took center stage at the April 2026 Heart Rhythm Society (HRS) Annual Meeting in Chicago. A pane…
Read more
A new self-organizing pencil beam imaging method from MIT could speed up drug tracking across the blood-brain barrier. L…
Read more
A new stem cell insulin therapy from Sweden reversed diabetes in mice. The approach reliably made insulin cells from hum…
Read more